C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 27, 2014, Pages 9899-9904

  Collins, Cailin ^a   Wang, Jingya ^a   Miao, Hongzhi ^a   Bronstein, Joel ^a   Nawer, Humaira ^a   Xu, Tao ^a   Figueroa, Maria ^a   Muntean, Andrew G ^a   Hess, Jay L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Enhancer; Gene regulation

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TRANSCRIPTION FACTOR HOXA9;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE TARGETING; LEUKEMOGENESIS; MOUSE; MURINE MODEL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SURVIVAL;

ENHANCER; GENE REGULATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; HOMEODOMAIN PROTEINS; LEUKEMIA, EXPERIMENTAL; MICE; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING;

EID: 84903954496     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1402238111     Document Type: Article

References (36)

1. Krumlauf R (1994) Hox genes in vertebrate development. Cell 78(2):191-201.
2. Eklund E (2011) The role of Hox proteins in leukemogenesis: Insights into key regulatory events in hematopoiesis. Crit Rev Oncog 16(1-2):65-76.
3. Sitwala KV, Dandekar MN, Hess JL (2008) HOX proteins and leukemia. Int J Clin Exp Pathol 1(6):461-474.
4. Golub TR, et al. (1999) Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring. Science 286(5439):531-537.
5. Shah N, Sukumar S (2010) The Hox genes and their roles in oncogenesis. Nat Rev Cancer 10(5):361-371.
6. Falini B, Sportoletti P, Martelli MP (2009) Acute myeloid leukemia with mutated NPM1: Diagnosis, prognosis and therapeutic perspectives. Curr Opin Oncol 21(6):573-581.
7. Mullighan CG, et al. (2007) Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias. Leukemia 21(9):2000-2009. (Pubitemid 47299976)
8. Zeisig BB, Kulasekararaj AG, Mufti GJ, So CW (2012) SnapShot: Acute myeloid leukemia. Cancer Cell 22(5):698-698.e1.
9. Huang Y, et al. (2012) Identification and characterization of Hoxa9 binding sites in hematopoietic cells. Blood 119(2):388-398.
10. Lawrence HJ, et al. (1999) Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias. Leukemia 13(12):1993-1999.
11. Kroon E, et al. (1998) Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J 17(13):3714-3725. (Pubitemid 28327389)
12. Armstrong SA, et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30(1):41-47.
13. Falini B, Nicoletti I, Martelli MF, Mecucci C (2007) Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): Biologic and clinical features. Blood 109(3):874-885. (Pubitemid 46220630)
14. Scholl C, et al. (2007) The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis. J Clin Invest 117(4):1037-1048. (Pubitemid 46556760)
15. Novak RL, et al. (2012) Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes. Exp Hematol 40(12):1016-1027.
16. Wang GG, Cai L, Pasillas MP, Kamps MP (2007) NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 9(7):804-812. (Pubitemid 47019467)
17. Mann RS, Lelli KM, Joshi R (2009) Hox specificity: Unique roles for cofactors and collaborators. Current Topics in Developmental Biology (Academic, New York), Vol 88, pp 63-101.
18. Laslo P, Pongubala JM, Lancki DW, Singh H (2008) Gene regulatory networks directing myeloid and lymphoid cell fates within the immune system. Semin Immunol 20(4):228-235.
19. Ye M, et al. (2013) C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nat Cell Biol 15(4):385-394.
20. Zhang DE, et al. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc Natl Acad Sci USA 94(2):569-574. (Pubitemid 27053674)
21. Feng R, et al. (2008) PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci USA 105(16):6057-6062. (Pubitemid 351758398)
22. Matsushita H, et al. (2008) C/EBPalpha and C/EBPvarepsilon induce the monocytic differentiation of myelomonocytic cells with the MLL-chimeric fusion gene. Oncogene 27(53):6749-6760.
23. Heinz S, et al. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38(4):576-589.
24. Figueroa ME, et al. (2010) DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell 17(1):13-27.
25. Ortega S, Malumbres M, Barbacid M (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602(1):73-87. (Pubitemid 34311901)
26. Drexler HG (1998) Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 12(6):845-859.
27. Williams RT, Sherr CJ (2008) The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias. Cold Spring Harb Symp Quant Biol 73:461-467.
28. Wolff L, Bies J (2013) p15Ink4b Functions in determining hematopoietic cell fates: implications for its role as a tumor suppressor. Blood Cells Mol Dis 50(4):227-231.
29. Nerlov C (2004) C/EBPalpha mutations in acute myeloid leukaemias. Nat Rev Cancer 4(5):394-400.
30. Alharbi RA, Pettengell R, Pandha HS, Morgan R (2013) The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia 27(5):1000-1008.
31. Agnelli L, et al. (2011) Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations. Am J Hematol 86(12):E64-E66.
32. Bhatlekar S, et al. (2014) Identification of a developmental gene expression signature, including HOX genes, for the normal human colonic crypt stem cell niche: Overexpression of the signature parallels stem cell overpopulation during colon tumorigenesis. Stem Cells Dev 23(2):167-179.
33. Cantile M, et al. (2012) Increased HOX C13 expression in metastatic melanoma progression. J Transl Med 10:91.
34. Reckzeh K, Cammenga J (2010) Molecular mechanisms underlying deregulation of C/EBPalpha in acute myeloid leukemia. Int J Hematol 91(4):557-568.
35. Zhang H, et al. (2013) Sox4 is a key oncogenic target in C/ EBPα mutant acute myeloid leukemia. Cancer Cell 24(5):575-588.
36. Smith LL, et al. (2011) Functional crosstalk between Bmi1 and MLL/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells. Cell Stem Cell 8(6):649-662.